Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Search Results - Home
Search
Search
Asset Entries
Any Asset
Web Content Article
(26)
Time
Any Time
Past Hour
(0)
Past 24 Hours
(0)
Past Week
(0)
Past Month
(0)
Past Year
(1)
Custom Range…
From
To
Search
No results were found that matched the keywords:
decessi covid-2019
.
Search
What evidence is there of their safety, since they were approved so quickly?
Web Content Article
The tests required by the authorities and carried out on the candidate vaccines against Sars-Cov-2 are the same as for all the other previously approved drugs and vaccines. In Europe, it was...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
How long after being vaccinated doHow long after being vaccinated does an individual acquire protection against the virus?
Web Content Article
The efficacy observed in clinical trials refers to a few days after the administration of the second dose. Therefore, maximum protection occurs after this period. Although, according to preliminary...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
What are the side effects?
Web Content Article
December 12th 2021 - Like all vaccines, Sars-Cov-2 vaccines can also cause side effects. During the trial, common reactions were observed, that were previously reported with other vaccinations....
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
In Italia i vaccini contro Sars-CoV-2 non arriveranno mai perché non sono stati ancora acquistati
Web Content Article
This result comes from the Italian version of this content.
FALSO. L’Italia è stata tra i primi Paesi al mondo a opzionare le quantità di vaccini necessarie per la somministrazione a tutta la popolazione. L’Italia infatti con Francia, Germania ed Olanda è...
Newsroom:
Special on COVID-19 » Vaccini » Fake news
Special on COVID-19 » Vaccini
Special on COVID-19
8 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 25 to 26 of 26 entries.
Previous Page
Page
1
Page
2
Page
3
Page
4
Next Page
Hidden